head activator peptide has been researched along with Idiopathic Parkinson Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Franke, I; Gelderblom, M; Glassmeier, G; Ignatov, A; Imai, Y; Rezgaoui, M; Schaller, HC; Süsens, U; Takahashi, R; Urny, J | 1 |
1 other study(ies) available for head activator peptide and Idiopathic Parkinson Disease
Article | Year |
---|---|
The neuropeptide head activator is a high-affinity ligand for the orphan G-protein-coupled receptor GPR37.
Topics: Animals; Calcium; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinases; Cell Death; Chlorocebus aethiops; COS Cells; Humans; Mitogens; Neuropeptides; Oocytes; Parkinson Disease; Phosphatidylinositol 3-Kinases; Pyrrolidonecarboxylic Acid; Receptors, G-Protein-Coupled; Transfection; Xenopus laevis | 2006 |